NK Cells

Dec 06, 2021

T-cell Immunoglobulin and ITIM domain (TIGIT) Inhibitor: An Insight into the Pipeline Development Activities, Major Collaborations, and Advancements

Aug 11, 2017

Natural Killer Cell Therapies– Advancing technology increasing competition among the companies

Newsletter/Whitepaper